Similar articles

• Amine uptake inhibitors: criteria of selectivity.

  Maître L, Moser P, Baumann PA, Waldmeier PC. Maître L, et al. Acta Psychiatr Scand Suppl. 1980;280:97-110. Acta Psychiatr Scand Suppl. 1980. PMID: 6996434 Review. No abstract available.
• Effects of Ro 11-2465, a new psychotropic agent on the uptake of serotonin by human platelets--in vitro determination of the IC50.

  Lenehan T, Omer LM, Darragh A. Lenehan T, et al. Arch Int Pharmacodyn Ther. 1981 Jan;249(1):147-52. Arch Int Pharmacodyn Ther. 1981. PMID: 7224716
• In vivo effect of danitracen on the uptake mechanisms in monoaminergic neurons and platelets in rats.

  Wielosz M, Przegaliński E, Kieinrok Z. Wielosz M, et al. Pol J Pharmacol Pharm. 1978 Mar-Jun;30(2-3):263-8. Pol J Pharmacol Pharm. 1978. PMID: 673930 No abstract available.
• A common uptake system for serotonin and dopamine in human platelets.

  Omenn GS, Smith LT. Omenn GS, et al. J Clin Invest. 1978 Aug;62(2):235-40. doi: 10.1172/JCI109121. J Clin Invest. 1978. PMID: 670392 Free PMC article.
• High-affinity binding of 3H-imipramine in brain and platelets: relevance to depression and antidepressant drugs.

  Langer SZ, Sette M, Raisman R, Briley M. Langer SZ, et al. Adv Biochem Psychopharmacol. 1982;31:171-7. Adv Biochem Psychopharmacol. 1982. PMID: 7044053 Review. No abstract available.